STOCK TITAN

[SCHEDULE 13G] Gossamer Bio, Inc. Passive Investment Disclosure (>5%)

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Gossamer Bio, Inc. reporting persons filed a joint Schedule 13G disclosing shared beneficial ownership positions in the issuer's Common Stock. The filing shows 37,665,073 shares reported for DeepCurrents/related parties (representing 7.7%) and 27,646,139 shares attributed to DCIG Capital Master Fund (representing 5.7%). The filing cites June 5, 2026 as the reference date for 488,846,722 shares outstanding used to calculate percentages.

The statement clarifies record ownership: the Fund and a separately managed account are direct owners, DeepCurrents is the investment manager, DCIG GP is the general partner, and Kai Zheng is a managing member. Each Reporting Person disclaims beneficial ownership of shares held directly by the others.

Positive

  • None.

Negative

  • None.

Insights

Large passive/managerial holdings reported without control claims.

The filing lists 37,665,073 shares (reported as 7.7%) attributed across DeepCurrents-related entities and a separately managed account, and 27,646,139 shares (reported as 5.7%) for DCIG Capital Master Fund, using an outstanding share base of June 5, 2026.

These positions are presented as shared voting/dispositive power rather than sole control; subsequent trading activity by the holders will determine any investor-visible supply pressure. Future Form 13D/13G amendments or sales would clarify intent and activity.

Filing is a joint Schedule 13G with standard disclaimers and group statements.

The document identifies the Fund and Managed Account as record owners and states managerial and GP relationships for DeepCurrents, DCIG GP, and Kai Zheng. It includes the joint filing agreement as Exhibit 99.1.

All declarative qualifiers and disclaimers are present; legal significance hinges on whether holdings remain passive. Any change in intent should trigger an amendment under applicable rules.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates





38341P102

(CUSIP Number)
06/04/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The figure in Item 6 represents shares of Common Stock, $0.0001 par value per share ("Common Stock") of Gossamer Bio, Inc. (the "Issuer") held by DCIG Capital Master Fund LP, a Delaware limited partnership (the "Fund"). (2) The figures in Items 8 and 9 include: (a) 27,646,139 shares of Common Stock held by the Fund, and (b) 10,018,934 shares of Common Stock held by a separately managed account. See Item 2 for more information. (3) The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on June 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The figures in Items 6, 8, and 9 represent shares of Common Stock held by the Fund. (2) The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G




Comment for Type of Reporting Person: (1) The figure in Items 6 represents shares of Common Stock held by the Fund. (2) The figures in Items 8 and 9 includes: (a) 27,646,139 shares of Common Stock held by the Fund, and (b) 10,018,934 shares of Common Stock held by a separately managed account. See Item 2 for more information. (3) The figure in Item 11 included above is based upon 488,846,722 shares of Common Stock outstanding as of June 5, 2026, as disclosed on the Issuer's Schedule 14A filed with the SEC on June 9, 2026.


SCHEDULE 13G



DeepCurrents Investment Group LLC
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member and President
Date:06/11/2026
DCIG GP LLC
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member
Date:06/11/2026
DCIG Capital Master Fund LP
Signature:DCIG GP LLC
Name/Title:General Partner
Date:06/11/2026
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng, Managing Member
Date:06/11/2026
Kai Zheng
Signature:/s/ Kai Zheng
Name/Title:Kai Zheng
Date:06/11/2026
Exhibit Information

Exhibit 99.1 - Joint Filing Agreement (filed herewith).